tiprankstipranks
Trending News
More News >
Editas Medicine Inc (EDIT)
NASDAQ:EDIT
US Market

Editas Medicine (EDIT) Financial Statements

Compare
3,552 Followers

Editas Medicine Financial Overview

Editas Medicine's market cap is currently $198.17M. The company's EPS TTM is $-0.28; its P/E ratio is -0.85; Editas Medicine is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 32.31M$ 78.12M$ 19.71M$ 25.54M$ 90.73M
Gross Profit$ 32.31M$ 72.06M$ 13.38M$ 20.49M$ -67.26M
Operating Income$ -251.15M$ -169.18M$ -225.95M$ -193.15M$ -134.84M
EBITDA$ -233.11M$ -163.12M$ -219.61M$ -188.09M$ -130.88M
Net Income$ -237.09M$ -153.22M$ -220.43M$ -192.50M$ -115.98M
Balance Sheet
Cash & Short-Term Investments$ 269.91M$ 323.11M$ 344.27M$ 499.85M$ 402.11M
Total Assets$ 341.59M$ 499.15M$ 514.32M$ 677.48M$ 572.60M
Total Debt$ 35.03M$ 48.54M$ 43.95M$ 26.38M$ 26.14M
Net Debt$ -96.51M$ -75.11M$ -97.58M$ -177.14M$ -113.55M
Total Liabilities$ 207.31M$ 150.06M$ 153.64M$ 123.84M$ 179.02M
Stockholders' Equity$ 134.27M$ 349.10M$ 360.68M$ 553.64M$ 393.59M
Cash Flow
Free Cash Flow$ -219.11M$ -136.90M$ -181.47M$ -171.78M$ -187.00M
Operating Cash Flow$ -210.28M$ -132.18M$ -177.35M$ -163.80M$ -179.84M
Investing Cash Flow$ 162.15M$ -3.73M$ 114.07M$ -54.47M$ -140.52M
Financing Cash Flow$ 56.03M$ 118.04M$ 1.28M$ 282.11M$ 224.12M
Currency in USD

Editas Medicine Earnings and Revenue History

Editas Medicine Debt to Assets

Editas Medicine Cash Flow

Editas Medicine Forecast EPS vs Actual EPS